logo
Share SHARE
FONT-SIZE Plus   Neg

Biogen Idec Sells BENLYSTA Royalty Rights To DRI Capital Managed Fund

Biogen Idec (BIIB) has sold to a DRI Capital managed fund its royalty and other rights pertaining to BENLYSTA to which Biogen Idec is entitled pursuant to a license deal with Human Genome Sciences Inc. (HGSI) and Glaxo Group Ltd. According to the agreement between Biogen Idec and DRI, Human Genome Sciences and Glaxo Group Ltd. would make royalty payments directly to DRI instead of to Biogen Idec. In turn, DRI would pay Biogen Idec a multiple of certain of the royalties received for the period covering October 2011 to September 2014.

Following that period, DRI would retain the royalty payments from BENLYSTA sales, with certain exceptions, including a one-time contingency payment that could be triggered if the cumulative royalties to DRI exceed an agreed amount. The initial payment by DRI to Biogen Idec, covering the royalty period from October 1, 2011 to March 30, 2012 is nearly $18.3 million and would be recognized into income as a gain in the third quarter.

BENLYSTA was approved by the US Food and Drug Administration in March 2011 and by the European Medicines Agency in July 2011 to treat systemic lupus erythematosus.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
At Home Group Inc., the home décor retail store with 115 stores in 29 states is planning to go public. The pricing of initial public offering is expected in a range of $14 to $16 per share. The company in a filing with the SEC said it has got the approval to list the shares on the NYSE under symbol "HOME." McDonald's Corp. has suspended sales of Big Macs in Venezuela as the fast food chain is unable to source buns - one of the key components of a burger. Venezuela is suffering from food shortages recently due to an ongoing economic and political crisis. Telecom giant Verizon Communications Inc. has agreed to acquire the operating business of struggling Internet company Yahoo Inc. for about $4.83 billion in cash, the two companies said Monday. The transaction is expected to close in the first quarter of 2017.
comments powered by Disqus
Follow RTT